Ligand validation:5UOC

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5UOC_BTB_D_504	75%	46%	0.122	0.954	0.59	1.47	-	1	6	0	100%	1
5UOC_BTB_C_504	64%	81%	0.134	0.932	0.35	0.47	-	-	5	0	100%	1
5UOC_BTB_B_504	63%	57%	0.156	0.953	0.4	1.25	-	1	7	0	100%	1
5UOC_BTB_A_505	59%	58%	0.148	0.931	0.56	1.03	-	1	2	0	100%	1
5UOC_BTB_A_504	59%	58%	0.175	0.958	0.46	1.13	-	1	1	0	100%	1
5UOC_BTB_A_506	53%	91%	0.096	0.857	0.33	0.26	-	-	1	0	100%	1
5UOC_BTB_C_505	42%	55%	0.225	0.945	0.66	1.05	-	-	4	0	100%	1
5UOC_BTB_C_506	38%	85%	0.177	0.88	0.37	0.38	-	-	5	0	100%	1
5UOC_BTB_B_506	27%	79%	0.142	0.787	0.42	0.44	-	-	2	0	100%	1
5UOC_BTB_D_505	25%	62%	0.295	0.935	0.4	1.05	-	-	4	0	100%	1
5UOC_BTB_B_505	14%	64%	0.303	0.851	0.38	0.97	-	-	2	0	100%	1
9CWK_BTB_B_505	100%	80%	0.025	0.996	0.31	0.53	-	-	2	0	100%	1
9CW6_BTB_C_504	100%	51%	0.028	0.996	0.41	1.45	-	1	4	0	100%	1
9CW4_BTB_C_504	100%	49%	0.032	0.995	0.42	1.5	-	2	2	0	100%	1
9CW9_BTB_D_504	100%	70%	0.036	0.994	0.39	0.76	-	-	1	0	100%	1
5UOB_BTB_B_504	100%	73%	0.038	0.994	0.58	0.47	-	-	3	0	100%	1
5O5D_BTB_A_604	100%	59%	0.022	0.994	0.89	0.68	1	-	2	0	100%	1
8F9X_BTB_J_305	100%	60%	0.032	0.992	0.86	0.66	-	-	5	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.